Navigation Links
First, do no harm: Study finds danger in standard treatment for a serious lung disease
Date:5/20/2012

bination to treat IPF patients similar to those in the trial, say the authors.

And, the dramatic finding of harm from a standard treatment should cause physicians to apply rigorous testing methods to other types of treatment, and highlights the importance of independent federal funding for such studies, says Martinez.

The authors salute the volunteer IPF patients who agreed to be randomly assigned to a treatment or placebo for 60 weeks.

Martinez, an internationally known IPF researcher and clinician in the U-M Medical School's Division of Pulmonary Medicine, remarks that results will soon be known for the group taking NAC alone, compared with those taking placebo. The current paper and presentation do not include results from this group.

In the results presented this week, the authors report that eight patients in the group of 77 assigned to the three-drug combination died, compared with one in the placebo group. A total of 23 of the three-drug patients were hospitalized during the trial, compared with 7 in the placebo group. There was no sign that the three-drug combination slowed the progression of IPF or improved lung function, as measured by forced vital capacity.

The study is called PANTHER-IPF, for Prednisone, Azathioprine, and N-Acetylcysteine: a Study That Evaluates Response in Idiopathic Pulmonary Fibrosis. Except for a donation of NAC and a matched placebo by the company that makes the drug, there was no industry support for the work.

IPF, which affects nearly 100,000 Americans, slowly steals the ability to breathe freely. Its cause or causes are not clear, which is why it is called "idiopathic." Over time it leads to the buildup of scar tissue in the lungs that accumulates in a distinctive honeycomb pattern that can be seen on biopsy or CT scan. It is known as an interstitial lung disease because it affects the tissue around the air sacs in the lungs.

IPF patients live an average of five years after d
'/>"/>

SOURCE University of Michigan Health System
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. In a World First, Asda Announces Not for Profit Price on All Cancer Treatment Drugs
2. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
3. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
4. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
5. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
6. CutisPharma Homogeneity and Stability Study for Mouthwash Compounding Kits Presented at NERDG Meeting
7. New Study Shows Long-Term Effects of Drug Prevention
8. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
9. Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
10. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
11. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... SAN DIEGO , Sept. 16, 2014 ... specialty pharmaceutical company dedicated to delivering high quality and ... today announced that Chief Executive Officer Mark Baum ... Annual Craig-Hallum Alpha Select Conference in New York ... including its Go Dropless™ campaign in ophthalmology. The ...
(Date:9/16/2014)...  Wearable sports and activity trackers will become ... years, producing a massive amount of user activity ... for leveraging this data to create meaningful healthcare ... first-of-its-kind wearable analytics platform for consumers, enterprises and ... linking activity and health risks, authored by its ...
(Date:9/16/2014)... , Sept. 16, 2014 Henry Schein, ... largest provider of health care products and services ... announced today that Stanley M. Bergman, Henry Schein,s Chairman of ... in a healthcare services panel at the Leerink ... Bergman will be Dr. Stohler, Dean of Columbia ...
Breaking Medicine Technology:Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3Henry Schein To Present At The Leerink Partners Services Roundtable 2
... Nov. 5, 2010 EnVivo Pharmaceuticals today announced it ... agonist, possesses a novel mechanism not previously seen in ... Acetylcholine (ACh) to enhance cognition. By acting ... makes it possible for smaller amounts of naturally occurring ...
... Nov. 5, 2010 Cadence Pharmaceuticals, Inc. (Nasdaq: ... developing and commercializing proprietary product candidates principally for use ... the three and nine months ended September 30, 2010. ... U.S. Food and Drug Administration (FDA) approved OFIRMEV™ (acetaminophen) ...
Cached Medicine Technology:EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist 2EnVivo Pharmaceuticals Research Shows EVP-6124 Acts as Acetylcholine Co-Agonist 3Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 2Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 3Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 4Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 5Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results 6
(Date:9/16/2014)... For patients with locally advanced pancreatic cancer, the ... may be a promising treatment option, ultimately allowing ... be an option, according to research presented today ... 56th Annual Meeting. , Surgery is the only ... adenocarcinoma (PDA), the most common type of pancreatic ...
(Date:9/16/2014)... The Pain Center of Arizona (TPC), ... has selected Analance ™, Ducen ’s BI ... TPC seeing hundreds of thousands of patients annually, the ... through “home grown” systems trying to piece together actionable ... “Our current tools were not scalable and, in ...
(Date:9/16/2014)... September 16, 2014 Cloud based ... Streaming (HLS) & UStream API’S to serve m3u8 streams ... feature for broadcasting live video events with hundreds of ... , The App Builder is known for making beautiful ... iOS, BlackBerry and Windows 8 and already over 100,000 ...
(Date:9/16/2014)... reduce the risk of heart disease or stroke, even ... part of the diet. , A study of ... from Monash University,s Department of Epidemiology and Preventive Medicine ... consumption of dairy foods had played in the country,s ... dominantly Chinese food culture, unaccustomed to dairy foods, consuming ...
(Date:9/16/2014)... workers die in motor vehicles than any other workplace ... to address at an international conference being hosted by ... Queensland (CARRS-Q). , The Occupational Safety in Transport Conference ... September 18 and 19 brings together experts from all ... mining to improve workplace health and safety. , CARRS-Q ...
Breaking Medicine News(10 mins):Health News:Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer 2Health News:Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer 3Health News:Chemotherapy and SABR consecutively may be promising treatment option for advanced pancreatic cancer 4Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3Health News:A heart-felt need for dairy food 2Health News:CARRS-Q Host International Transport Safety Conference 2
... ... AZ (Vocus) December 23, 2008 -- Adding to a growing body of ... the December 23rd issue of Circulation further emphasized the need to exercise ... most Americans fall far short of the minimum recommended guidelines of physical ...
... Center for Clinical and Translational Science (CCTS) has ... third annual pilot-project grant program. The grants, which ... early studies in translational science that, if successful, ... CCTS, established through funds from a 2006 Clinical ...
... dangers, researchers say , , TUESDAY, Dec. 23 (HealthDay News) ... in the United States combine over-the-counter medications with prescription ... potentially dangerous interactions, a new survey finds. , A ... more than 175,000 emergency department visits for adverse drug ...
... sports such as swimming had greater bone density in menopause ... exercise during adolescence may help women maintain their bone strength ... Dec. 22 in the British Journal of Sports Medicine ... the teenage exercise habits of 46 postmenopausal women, now aged ...
... perihepatic capsules with concomitant pelvic inflammation. The pain ... main symptom. These cases have to be cautiously ... is pain in the right upper abdomen Fitz-Hugh-Curtis ... that can be diagnosed by non-invasive methoids and ...
... presenting cells (APCs) that both initiate and modulate the ... antigen capture and presentation to T cells, with the ... T cells. Gastric cancer is one of the most ... progress, it is still difficult to treat advanced gastric ...
Cached Medicine News:Health News:Treadmill Desks to the Rescue: Weight Control and Activity Critical in Preventing Heart Failure 2Health News:Rockefeller University's Center for Clinical and Translational Science funds 18 new pilot studies 2Health News:Rockefeller University's Center for Clinical and Translational Science funds 18 new pilot studies 3Health News:Rockefeller University's Center for Clinical and Translational Science funds 18 new pilot studies 4Health News:Drug Combinations Putting Seniors at Risk 2Health News:Drug Combinations Putting Seniors at Risk 3Health News:Drug Combinations Putting Seniors at Risk 4Health News:What is the clinical character of Fitz-Hugh-Curtis syndrome? 2Health News:A new light on tumor immunotherapy for gastric cancer 2
...
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein....
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: